14-day Premium Trial Subscription Sign Up For FreeGet Free

Windtree Therapeutics Inc Stock Forecast NASDAQ:WINT

$1.74 (-1.14%)

Volume: 178k

Closed: Nov 29, 2021

Hollow Logo Score: -2.446

Windtree Therapeutics Inc Stock Forecast

$1.74 (-1.14%)

Volume: 178k

Closed: Nov 29, 2021

Score Hollow Logo -2.446
Which way will WINT go? Request

WINT Stock Risk

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0600 between high and low, or 3.49%. For the last week the stock has had a daily average volatility of 7.22%.

Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 20 - 80 ] RSI14 is 45 and the stock is currently not being overbought or oversold

Windtree Therapeutics Inc stock price down 1.14% on Monday
(Updated on Nov 29, 2021)


Sell candidate since 2021-11-17 Gain 3.57%

The Windtree Therapeutics Inc stock price fell by -1.14% on the last day (Monday, 29th Nov 2021) from $1.76 to $1.74. During the day the stock fluctuated 3.49% from a day low at $1.72 to a day high of $1.78. The price has fallen in 7 of the last 10 days and is down by -2.25% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -48 thousand shares and in total, 178 thousand shares were bought and sold for approximately $309.61 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.59% during the next 3 months and, with a 90% probability hold a price between $1.34 and $1.94 at the end of this 3-month period.

Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Windtree Therapeutics Inc stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $1.87. On a fall, the stock will find some support from the short-term average at $1.66. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, November 26, 2021, and so far it has fallen -1.14%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss

Windtree Therapeutics Inc finds support from accumulated volume at $1.68 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0600 between high and low, or 3.49%. For the last week the stock has had a daily average volatility of 7.22%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Windtree Therapeutics Inc stock A Buy?

Windtree Therapeutics Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.446

Predicted Opening Price for Windtree Therapeutics Inc of Tuesday, November 30, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 30, 2021 Current price
$1.75 $1.74 (Undervalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

Oppenheimer is very positive about WINT and gave it a "Outperform" rating on Jun 04, 2021. The price target was set to $8.00.

Volatility and Risk
Daily Average Volatility: 7.22 %
Overall Risk: Very High High Medium Low Very Low
Volatility
7.22 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $1.90
Price: $1.74
Support: $1.68

WINT Insider Trading Show all Trades

INSIDER POWER

130.316

Last 100 transactions
Buy: 10 093 787 | Sell: 77 456 (Shares)
Date Action Amount Person Type
Nov 19, 2021 Buy 930 Fraser Craig Common Stock
Nov 18, 2021 Buy 930 Fraser Craig Common Stock
Oct 22, 2021 Buy 3 000 Fraser Craig Common Stock
Oct 19, 2021 Buy 50 000 Huang James Common Stock
Oct 19, 2021 Buy 3 000 Fraser Craig Common Stock
Show all Insider Trades
INSIDER POWER

130.316

Last 100 transactions
Buy: 10 093 787 | Sell: 77 456 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 1.81 3.83 %
1.78 2.51 %
1.77 1.70 %
Current price: 1.74
Support 1.72 -0.93 %
1.71 -1.75 %
1.69 -3.07 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 2.08 19.54 %
2.06 18.39 %
1.90 9.20 %
Current price 1.74
Support 1.68 -3.45%
1.56 -10.34%
1.51 -13.22%

Click to get the best stock tips daily for free!

About Windtree Therapeutics Inc

Windtree Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing novel surfactant therapies for respiratory diseases and other potential applications. Its proprietary technology platform produces a synthetic peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant — and novel drug-delivery technologies being developed to enable noninvasive administration of aerosoliz... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT